Abstract:BACKGROUND:Primary liver cancer (PLC) is one of the most frequently seen tumors in China. Thirty years ago, patients with PLC were often detected at relatively late stage, with a palpable mass or marked clinical symptoms and poor prognosis. In the past 30 years, the diagnosis and treatment of PLC have been greatly improved with better prognosis.METHODS:In order to study the changes of PLC during the 30 years, the clinical data of 3250 patients with PLC from 10 medical institutions of China were collected, analyzed, and compared with those of 3254 PLC patients before the 30 years.RESULTS:In the 3250 patients aged 1-80 years, with an average age of 49.1 years, the male to female ratio (2.3:1) was lower than that before the 30 years. 73.5% of the 3250 patients sought medical advice within 3 months after the onset of the disease in contrast to 63.8% before the 30 years. Compared with those patients before the 30 years the symptoms and signs were alleviated generally. The HBsAg positive rate was 81.0%, but the HCV-Ab positive rate was 13.2%. The AFP level in 75% of patients was elevated, but in the remaining 25% was normal. 1912 patients (58.8%) were confirmed pathologically. Among them 1755 patients (91.8%) had hepatocellular carcinoma. The overall resection rate was 46.3%. Those who had early, middle, late stage carcinoma accounted for 29.9%, 51.5%, and 18.6% respectively in contrast to 0.4%, 47.0%, and 52.6% reported before the 30 years. The 1-, 3-, 5-year survival rates of the patients were 66.1%, 39.7%, and 32.5% respectively, whereas 93.5%, 70.1%, and 59.1% for the early stage patients, and 65.3%, 30.5%, and 23.5% for the middle stage patients. The half and 1-year survival rates of the late stage patients were 52.5%, and 14.7%, respectively.CONCLUSION:Comparison with the clinical data before and after the 30 years show that PLC can be diagnosed early. More PLC patients tend to undergo resection while receiving a better conservative treatment, which ensures a prognosis.

The Changing Role of Surgery in the Treatment of Primary Liver Cancer

Surgery for Primary Liver Cancer: A Forty Years Survey

Three Decades of Progress in Surgery for Primary Liver Cancer

Surgical Treatment of Primary Liver Cancer: Report of 5524 Patients

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

[Ten-Year Retrospect of ALPPS in the Treatment of Hepatocellular Carcinoma:An Eternal Concept with Cautious Technologic Choice].

[Surgery for Patients with Primary Liver Cancer: Report of 1,038 Patients].

Changed Clinical Aspects of Primary Liver Cancer in China During the Past 30 Years.

Evolution of Surgery in the Treatment of Hepatocellular-Carcinoma from the 1950s to the 1990S

Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection

Long-term Results of Surgery for Small Primary Liver Cancer in 514 Adults

Prognostic Factors Of Primary Liver-Cancer - Report Of 83 Patients Surviving 5 Years Or More Compared With 811 Patients Surviving Less Than 5 Years

Cytoreduction and Sequential Resection - A Hope for Unresectable Primary Liver-Cancer

Perioperative Management of Primary Liver Cancer

[Changes of Clinical Aspect of Primary Liver Cancer in China During the Past 30 Years--control Study for 3,250 Cases with Primary Liver Cancer].

Multimodality Treatment in Advanced Primary Liver Cancer.

Results of Liver Resection for Primary Liver Cancer

Surgical Treatment for Primary Liver Cancer

Surgery for large primary liver cancer more than 10 cm in diameter

Surgical individualized treatment for primary liver cancer with portal hypertension and hypersplenism

Recent research progress on surgery combined with radiation therapy for primary liver cancer